S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Advisor to FBI: Sell META now (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Advisor to FBI: Sell META now (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Advisor to FBI: Sell META now (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Advisor to FBI: Sell META now (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Advisor to FBI: Sell META now (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Advisor to FBI: Sell META now (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Advisor to FBI: Sell META now (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Advisor to FBI: Sell META now (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:IRMD

IRadimed (IRMD) Stock Forecast, Price & News

$43.28
-0.18 (-0.41%)
(As of 09/25/2023 ET)
Compare
Today's Range
$42.92
$43.78
50-Day Range
$43.28
$50.31
52-Week Range
$26.00
$51.04
Volume
17,211 shs
Average Volume
37,462 shs
Market Capitalization
$545.33 million
P/E Ratio
37.31
Dividend Yield
N/A
Price Target
$54.00

IRadimed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
24.8% Upside
$54.00 Price Target
Short Interest
Healthy
1.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.85
Upright™ Environmental Score
News Sentiment
0.51mentions of IRadimed in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$3.59 M Sold Last Quarter
Proj. Earnings Growth
18.11%
From $1.27 to $1.50 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.90 out of 5 stars

Medical Sector

44th out of 961 stocks

Surgical & Medical Instruments Industry

5th out of 97 stocks


IRMD stock logo

About IRadimed (NASDAQ:IRMD) Stock

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IRMD Price History

IRMD Stock News Headlines

Iradimed Corp
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Short Interest in IRadimed Co. (NASDAQ:IRMD) Declines By 7.2%
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Lake Street Keeps Their Buy Rating on Iradimed (IRMD)
IRadimed (NASDAQ: IRMD)
iRadimed Stock (NASDAQ:IRMD), Dividends
See More Headlines
Receive IRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter.

IRMD Company Calendar

Last Earnings
8/03/2023
Today
9/25/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRMD
Employees
123
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$54.00
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$48.00
Forecasted Upside/Downside
+24.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$12.83 million
Pretax Margin
31.05%

Debt

Sales & Book Value

Annual Sales
$53.30 million
Cash Flow
$1.07 per share
Book Value
$5.86 per share

Miscellaneous

Free Float
7,234,000
Market Cap
$545.33 million
Optionable
Not Optionable
Beta
0.99
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Roger E. Susi (Age 70)
    Founder, Chairman, CEO & Pres
    Comp: $586.04k
  • Mr. John F. Glenn (Age 61)
    CFO & Corp. Sec.
    Comp: $411.79k
  • Mr. Randy Waddell
    VP of Worldwide Sales & Marketing
  • Mr. Steve Kachelmeyer
    VP of Regulatory Affairs & Quality Assurance
  • Mr. Lynn Neuhardt
    VP of R&D
  • Mr. Chris Williamson
    Exec. VP of Continuous Improvement & Information Technology
  • Mr. Matt Garner
    Controller













IRMD Stock - Frequently Asked Questions

Should I buy or sell IRadimed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings
or view top-rated stocks.

What is IRadimed's stock price forecast for 2023?

1 brokers have issued 12 month target prices for IRadimed's shares. Their IRMD share price forecasts range from $48.00 to $60.00. On average, they anticipate the company's stock price to reach $54.00 in the next year. This suggests a possible upside of 24.8% from the stock's current price.
View analysts price targets for IRMD
or view top-rated stocks among Wall Street analysts.

How have IRMD shares performed in 2023?

IRadimed's stock was trading at $28.29 at the beginning of the year. Since then, IRMD shares have increased by 53.0% and is now trading at $43.28.
View the best growth stocks for 2023 here
.

Are investors shorting IRadimed?

IRadimed saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 76,000 shares, a decline of 7.2% from the August 15th total of 81,900 shares. Based on an average daily trading volume, of 36,800 shares, the short-interest ratio is currently 2.1 days. Currently, 1.0% of the shares of the stock are sold short.
View IRadimed's Short Interest
.

When is IRadimed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our IRMD earnings forecast
.

How were IRadimed's earnings last quarter?

IRadimed Co. (NASDAQ:IRMD) issued its quarterly earnings results on Thursday, August, 3rd. The medical equipment provider reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.05. The medical equipment provider had revenue of $16.13 million for the quarter, compared to analysts' expectations of $15.70 million. IRadimed had a net margin of 24.53% and a trailing twelve-month return on equity of 21.22%.

How often does IRadimed pay dividends? What is the dividend yield for IRadimed?

IRadimed announced a dividend on Monday, February 6th. Stockholders of record on Monday, February 13th will be given a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is a positive change from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD
.

What ETF holds IRadimed's stock ?

Ballast Small/Mid Cap ETF holds 19,404 shares of IRMD stock, representing 0.98% of its portfolio.

What guidance has IRadimed issued on next quarter's earnings?

IRadimed issued an update on its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.36-$0.38 for the period, compared to the consensus EPS estimate of $0.33. The company issued revenue guidance of $16.10 million-$16.30 million, compared to the consensus revenue estimate of $15.60 million.

What other stocks do shareholders of IRadimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

What is IRadimed's stock symbol?

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

Who are IRadimed's major shareholders?

IRadimed's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (4.62%), BlackRock Inc. (3.94%), RK Capital Management LLC (2.29%), Bares Capital Management Inc. (2.20%), Ranger Investment Management L.P. (1.78%) and Russell Investments Group Ltd. (1.73%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends
.

How do I buy shares of IRadimed?

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRadimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $43.28.

How much money does IRadimed make?

IRadimed (NASDAQ:IRMD) has a market capitalization of $545.33 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.16 on an earnings per share basis.

How many employees does IRadimed have?

The company employs 123 workers across the globe.

How can I contact IRadimed?

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.

This page (NASDAQ:IRMD) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -